Cargando…
Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
BACKGROUND: Tacrolimus (TAC) is a powerful remission-inducing drug for refractory ulcerative colitis (UC). However, it is unclear whether mucosal healing (MH) influences relapse after completion of TAC.We investigated whether MH is related to relapse after TAC. Patients: Among 109 patients treated w...
Autores principales: | Ito, Ayumi, Murasugi, Syun, Omori, Teppei, Nakamura, Shinichi, Tokushige, Katsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320561/ https://www.ncbi.nlm.nih.gov/pubmed/32590945 http://dx.doi.org/10.1186/s12876-020-01317-9 |
Ejemplares similares
-
Development and Improvement of Simple Colonic Mucosal Ulcer during Treatment of Severe Ulcerative Colitis with Tacrolimus
por: Ito, Ayumi, et al.
Publicado: (2017) -
Retrospective investigation of tacrolimus combined with an anti‐tumor necrosis factorα antibody as remission induction therapy for refractory ulcerative colitis: Efficacy, safety, and relapse rate
por: Ito, Ayumi, et al.
Publicado: (2019) -
Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
por: Murasugi, Shun, et al.
Publicado: (2020) -
Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study
por: Ito, Ayumi, et al.
Publicado: (2016) -
Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
por: Ito, Ayumi, et al.
Publicado: (2017)